Almousa Health FY revenue 1.42B riyals, +18% y/y

Almoosa Health Co. reported fiscal year-to-date revenue of SAR 1,028.3 million for the nine months ended September 30, 2025, reflecting an 18.2% year-over-year (YoY) increase driven by expanded clinic operations, higher patient volumes, and improved service utilization according to financial reports. The company's net profit surged 282.4% YoY to SAR 154.5 million, supported by operational efficiencies and reduced finance costs after settling loans earlier in the year as reported.

Quarterly performance showed mixed trends: Q3 revenue rose 2.1% sequentially to SAR 356.4 million, while net profit declined marginally by 0.3% to SAR 51.6 million, attributed to incremental costs from newly launched medical centers according to the report. Operational profitability remained resilient, with EBITDA growing 11.2% YoY to SAR 79.8 million in Q3 2025 according to financial data.

The Board approved a SAR 0.35 per-share dividend (SAR 15.5 million total) for Q3 2025, and total shareholders' equity increased 193.8% to SAR 1,945.1 million compared to the prior year as reported. Auditors provided an unmodified opinion on the financial statements, affirming their accuracy according to audit findings. These results highlight the company's expansion strategy and cost management efforts amid ongoing market growth.